The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of McNeer, Jennifer L.
PropertyValue
keywords Adolescent and Young Adult Leukemia
keywords Adolescent and Young Adult Lymphoma
overview Jennifer McNeer, MD, MS, treats patients with all types of blood disorders and childhood cancers. She has a particular interest in the treatment of benign and malignant hematological diseases, including pediatric, adolescent, and young adult leukemia and lymphoma. Dr. McNeer is a clinical researcher, focusing on improving treatment strategies for high-risk leukemia patients. She is an active member of the Acute Lymphoblastic Leukemia Committee within the Children's Oncology Group, and is co-director of the University of Chicago Adolescent and Young Adult Oncology Program.
One or more keywords matched the following items that are connected to McNeer, Jennifer L.
Item TypeName
Concept Adolescent
Academic Article Early elevation of C-reactive protein correlates with severe infection and nonrelapse mortality in children undergoing allogeneic stem cell transplantation.
Academic Article The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers.
Academic Article Acute lymphoblastic leukemia in young adults: which treatment?
Academic Article Pediatric Hematology, Oncology, and Stem Cell Transplantation.
Academic Article Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship.
Academic Article Repeated Blood Cultures in Pediatric Febrile Neutropenia: Would Following the Guidelines Alter the Outcome?
Academic Article Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL).
Academic Article Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.
Academic Article Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults.
Academic Article Patient-Reported Health-Related Quality-of-Life Assessment at the Point-of-Care with Adolescents and Young Adults with Cancer.
Academic Article Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
Academic Article Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.
Academic Article Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial.
Academic Article Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study.
Academic Article How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment.
Academic Article Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia.
Academic Article Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia.
Academic Article Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group.
Search Criteria
  • Adolescent